EXTENDED URINARY A9-TETRAHYDROCANNABINOL EXCRETION IN CHRONIC CANNABIS USERS PRECLUDES USE AS A BIORMARKER OF NEW DRUG EXPOSURE
Saved in:
LOWE, R.H., ET AL., EXTENDED URINARY A9-TETRAHYDROCANNABINOL EXCRETION IN CHRONIC CANNABIS USERS PRECLUDES USE AS A BIORMARKER OF NEW DRUG EXPOSURE. DRUG AND ALCOHOL DEPENDENCE, Vol. 105, no. 1-2 (2009), p. 24-32.
Ref.
164531
Location:
SIIS R.854 Archivo
Palabras clave:
Cannabis, Detección, Drogodependencias, Micción, Tests, Validez, EE.UU.
Cannabis, Detección, Drogodependencias, Micción, Tests, Validez, EE.UU.
Similar Items: EXTENDED URINARY A9-TETRAHYDROCANNABINOL EXCRETION IN CHRONIC CANNABIS USERS PRECLUDES USE AS A BIORMARKER OF NEW DRUG EXPOSURE
- INCONTINENCIA URINARIA . CONCEPTOS ACTUALES
- URINARY CATECHOLAMINE EXCRETION IN SEXUALLY ABUSED GIRLS
- DIFFERENTIATING NEW CANNABIS USE FROM RESIDUAL URINARY CANNABINOID EXCRETION IN CHRONI, DAILY CANNABIS USERS
- DO A9 TETRAHYDROCANNABINOL CONCENTRATIONS INDICATE RECENT USE IN CHRONIC CANNABIS USERS?
- BONE COLLAGEN, MINERAL AND TRACE ELEMENT COMPOSITION, HISTOMORPHOMETRY AND URINARY HIDROXYPROLINE EXCRETION IN CHRONICALLY-TREATED ALCOHOL-FED RATS
- INFANTILE AUTISM AND URINARY EXCRETION OF PEPTIDES AND PROTEIN-ASSOCIATED PEPTIDE COMPLEXES